312 results on '"Kang, Chunsheng"'
Search Results
2. MET fusions and splicing variants convergently define a subgroup of glioma sensitive to MET inhibitors
3. CACA guidelines for holistic integrative management of glioma
4. Deep‐targeted gene sequencing reveals ARID1A mutation as an important driver of glioblastoma
5. Virus-like nanoparticle as a co-delivery system to enhance efficacy of CRISPR/Cas9-based cancer immunotherapy
6. CRISPR-Cas9 library screening combined with an exosome-targeted delivery system addresses tumorigenesis/TMZ resistance in the mesenchymal subtype of glioblastoma
7. Retraction of “Universal theranostic CRISPR/Cas13a RNA-editing system for glioma”
8. Blockage of EGFR/AKT and mevalonate pathways synergize the antitumor effect of temozolomide by reprogramming energy metabolism in glioblastoma
9. Elevated signature of a gene module coexpressed with CDC20 marks genomic instability in glioma
10. EPIC-1042 as a potent PTRF/Cavin1-Caveolin-1 interaction inhibitor to induce PARP1 autophagic degradation and suppress temozolomide efflux for Glioblastoma
11. EPIC-0307-mediated selective disruption of PRADX–EZH2 interaction and enhancement of temozolomide sensitivity to glioblastoma via inhibiting DNA repair and MGMT
12. EGFR-vIII downregulated H2AZK4/7AC though the PI3K/AKT-HDAC2 axis to regulate cell cycle progression
13. RUNX1 contributes to the mesenchymal subtype of glioblastoma in a TGFβ pathway-dependent manner
14. Expert opinion on translational research for advanced glioblastoma treatment
15. Editorial: Innovative theranostic approaches towards neuro-immunology in gliomas
16. Lnc-TALC promotes O6-methylguanine-DNA methyltransferase expression via regulating the c-Met pathway by competitively binding with miR-20b-3p
17. Bridging deep sequencing to precision oncology in meningiomas
18. Universal theranostic CRISPR/Cas13a RNA-editing system for glioma
19. A novel compound EPIC-0412 reverses temozolomide resistance via inhibiting DNA repair/MGMT in glioblastoma
20. Star-branched amphiphilic PLA-b-PDMAEMA copolymers for co-delivery of miR-21 inhibitor and doxorubicin to treat glioma
21. A novel compound EPIC-0412 reverses temozolomide resistance via inhibiting DNA repair/MGMT in glioblastoma.
22. PRMT2 links histone H3R8 asymmetric dimethylation to oncogenic activation and tumorigenesis of glioblastoma
23. Engineering chimeric antigen receptor-T cells for cancer treatment
24. MET fusions and splicing variants convergently define a subgroup of glioma sensitive to MET inhibitors
25. lncRNA PRADX is a Mesenchymal Glioblastoma Biomarker for Cellular Metabolism Targeted Therapy
26. Blood exosomes-based targeted delivery of cPLA2 siRNA and metformin to modulate glioblastoma energy metabolism for tailoring personalized therapy
27. PTRF/Cavin-1 as a Novel RNA-Binding Protein Expedites the NF-κB/PD-L1 Axis by Stabilizing lncRNA NEAT1, Contributing to Tumorigenesis and Immune Evasion in Glioblastoma
28. PTRF/Cavin-1 enhances chemo-resistance and promotes temozolomide efflux through extracellular vesicles in glioblastoma
29. Neuronal STAT3/HIF-1α/PTRF axis-mediated bioenergetic disturbance exacerbates cerebral ischemia-reperfusion injury via PLA2G4A
30. TCA-phospholipid-glycolysis targeted triple therapy effectively suppresses ATP production and tumor growth in glioblastoma
31. RETRACTED: Precise editing of FGFR3-TACC3 fusion genes with CRISPR-Cas13a in glioblastoma
32. ALKBH5 Facilitates Hypoxia-Induced Paraspeckle Assembly and IL8 Secretion to Generate an Immunosuppressive Tumor Microenvironment
33. HOTAIR Up-Regulation Activates NF-κB to Induce Immunoescape in Gliomas
34. Precise editing of FGFR3-TACC3 fusion genes with CRISPR-Cas13a in glioblastoma
35. Editorial: The State-of-Art in Immuno-Oncology, What to Do With Glioblastoma?
36. Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status
37. Single-Cell Transcriptomics of Glioblastoma Reveals a Unique Tumor Microenvironment and Potential Immunotherapeutic Target Against Tumor-Associated Macrophage
38. miR-19a and miR-19b Overexpression in Gliomas
39. Antisense MMP-9 RNA inhibits malignant glioma cell growth in vitro and in vivo
40. Clinical practice guidelines for the management of adult diffuse gliomas
41. Differential Expression of Notch Family Members in Astrocytomas and Medulloblastomas
42. Comprehensive analysis of the functional microRNA–mRNA regulatory network identifies miRNA signatures associated with glioma malignant progression
43. MicroRNA and brain tumors
44. Suppression of glioma-cell survival by antisense and dominant-negative AKT2 RNA
45. LncRNA PRADX-mediated recruitment of PRC2/DDX5 complex suppresses UBXN1 expression and activates NF-κB activity, promoting tumorigenesis
46. Early administration of MPC-n(IVIg) selectively accumulates in ischemic areas to protect inflammation-induced brain damage from ischemic stroke
47. Rapid design and development of CRISPR-Cas13a targeting SARS-CoV-2 spike protein
48. FUNDC1-dependent mitophagy induced by tPA protects neurons against cerebral ischemia-reperfusion injury
49. Premature MicroRNA-Based Therapeutic: A “One-Two Punch” against Cancers
50. Treatment Progress of Immune Checkpoint Blockade Therapy for Glioblastoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.